EpCAM overexpression in carcinomas is linked to cancer proliferation, migration, and metastasis (Trzpis et al., 2007), and is associated with poor prognosis (Spizzo et al., 2002, 2004; Varga et al., 2004; Fong et al., 2007; Brunner et al., 2008; Scheunemann et al., 2008; Chen et al., 2014). Here, EPCAM is linked to carcinoma.